https://priyalifescience.com/article/mgs-mfg-group-leixlip-cleanroom-expansion-2026 2026-07-14T18:02:45+00:00 Priya Life Science en 2026-07-14T18:02:45+00:00 MGS Mfg. Group Scales Up European Healthcare Manufacturing with 115,000 Sq Ft Leixlip Hub Biotechnology, mgs mfg group leixlip cleanroom expansion 2026, pharma Ireland, life science Ireland, pharmaceutical news Ireland, biopharma Europe, EMA, HPRA, biotech Ireland, MedTech Ireland https://priyalifescience.com/assets/images/mgs_cleanroom.png https://priyalifescience.com/article/ireland-eu-presidency-biotech-act-incentives-2026 2026-07-14T18:02:45+00:00 Priya Life Science en 2026-07-14T18:02:45+00:00 Irish EU Council Presidency Prioritizes €10B Biotech Act to Revitalize European Clinical Trials and Sovereign Biomanufacturing Regulatory Affairs, ireland eu presidency biotech act incentives 2026, pharma Ireland, life science Ireland, pharmaceutical news Ireland, biopharma Europe, EMA, HPRA, biotech Ireland, MedTech Ireland https://priyalifescience.com/assets/images/jennifer_carroll_macneill.png https://priyalifescience.com/article/ireland-drug-approval-system-orphan-medicines-reform-2026 2026-07-14T18:02:45+00:00 Priya Life Science en 2026-07-14T18:02:45+00:00 Addressing the 801-Day Lag: Ireland’s Drug Approval System Demands Urgent Structural Reform Regulatory Affairs, ireland drug approval system orphan medicines reform 2026, pharma Ireland, life science Ireland, pharmaceutical news Ireland, biopharma Europe, EMA, HPRA, biotech Ireland, MedTech Ireland https://priyalifescience.com/assets/images/ireland_drug_approval.png